EUROPEAN ONCOLOGY & HAEMATOLOGY – SUPPLEMENT 1 (GI CANCER) – 2017
GASTROINTESTINAL CANCER SUPPLEMENT
Introducing the latest European Oncology & Haematology supplement on gastrointestinal oncology titled State-of-the-art Integration of Multikinase Inhibitors in the Treatment of Gastrointestinal Cancers.
Targeting kinase pathways to treat progressive gastrointestinal stromal tumours and sarcomas Gastrointestinal stromal tumours Medications that target multiple kinase pathways have proven to be a successful and are a frequently used approach in treating progressive gastrointestinal stromal tumours (GISTs), which are the most common type of sarcomas.1–4 Tyrosine kinase inhibitors (TKIs), which have shown efficacy […]
Trending Topic
Esophageal cancer (EC) is a major global health concern, ranking as the 11th most commonly diagnosed cancer and the seventh leading cause of cancer-related deaths worldwide, with an estimated 494,320 new cases and 441,994 deaths in 2024.1 Esophageal squamous cell carcinoma (ESCC) remains the predominant subtype globally (84% of new cases), while esophageal adenocarcinoma (EAC) […]
Journal Archive
Comprising articles contributed by renowned thought leaders, European Oncology & Haematology is a peer reviewed, free-to-access, bi-annual journal that aims to disseminate best practice through review articles addressing the most important and salient developments in the Oncological & Haematology field in practical terms.
European Oncology & Haematology
Frequency: Two print issues per year (Summer & Winter); ePub ahead of print throughout the year.
Print ISSN: 2045-5275 Electronic ISSN: 2045-5283
Indexing: EMBASE, Google Scholar, Genamics JournalSeek
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
